Purpose of this Study
We are doing this study to determine whether specialty palliative care or primary palliative care is the best way to improve the quality of life and experience of patients and their caregivers.
Who Can Participate?
Eligibility
Adults ages 18+ who:<ul>
<li>Are hospitalized with high-risk AML</li>
<li>Are receiving treatment with either intensive chemotherapy (7+3) or modification of this regimen on a clinical trial, or a similar intensive regimen requiring prolonged hospitalization, or hypomethylating agents+/-additional agents or modification of this regimen on a clinical trial</li></ul>
For more information about who can join this study, please contact the study team at <a href= "mailto: dbc6@duke.edu">dbc6@duke.edu.</a>
<li>Are hospitalized with high-risk AML</li>
<li>Are receiving treatment with either intensive chemotherapy (7+3) or modification of this regimen on a clinical trial, or a similar intensive regimen requiring prolonged hospitalization, or hypomethylating agents+/-additional agents or modification of this regimen on a clinical trial</li></ul>
For more information about who can join this study, please contact the study team at <a href= "mailto: dbc6@duke.edu">dbc6@duke.edu.</a>
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
If you choose to join this study, you will:<ul>
<li>Fill out study questionnaires about your health and how you are feeling</li>
<li>Let us know a caregiver (family member or close friend who is helping you) who may be interested in taking part in the study</li>
<li>Receive primary palliative care during your current and future hospital stay by trained oncology clinicians</li></ul>
<li>Fill out study questionnaires about your health and how you are feeling</li>
<li>Let us know a caregiver (family member or close friend who is helping you) who may be interested in taking part in the study</li>
<li>Receive primary palliative care during your current and future hospital stay by trained oncology clinicians</li></ul>
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
PROTOCOL TITLE: Specialty Compared to Oncology Delivered Palliative Care for Patients with Acute Myeloid Leukemia – SCOPE-Leukemia
Principal Investigator
Thomas
Leblanc
Protocol Number
PRO00110266
NCT ID
NCT05237258
Phase
N/A
Enrollment Status
Open to Enrollment